$644 Million is the total value of BVF INC/IL's 34 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 37.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $80,649,000 | -4.1% | 1,591,646 | -24.3% | 12.52% | -12.4% |
| ANAB | Sell | ANAPTYSBIO INC | $39,705,000 | -17.7% | 1,659,200 | -4.6% | 6.17% | -24.9% |
| CNCE | Sell | CONCERT PHARMACEUTICALS INC | $25,904,000 | -35.0% | 1,856,895 | -20.5% | 4.02% | -40.7% |
| CYTK | Sell | CYTOKINETICS INC | $24,083,000 | -56.0% | 1,990,321 | -53.3% | 3.74% | -59.8% |
| FATE | Sell | FATE THERAPEUTICS INC | $1,268,000 | -85.7% | 391,386 | -79.9% | 0.20% | -86.9% |
| PTIE | Exit | PAIN THERAPEUTICS INC | $0 | – | -2,278,552 | -100.0% | -0.35% | – |
| ANTH | Exit | ANTHERA PHARMACEUTICALS INC | $0 | – | -8,052,073 | -100.0% | -0.58% | – |
| IMDZ | Exit | IMMUNE DESIGN CORP | $0 | – | -1,233,976 | -100.0% | -1.43% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 36 | Q3 2023 | 4.7% |
| PIERIS PHARMACEUTICALS INC | 30 | Q3 2023 | 2.8% |
| CYTOKINETICS INC | 29 | Q4 2020 | 11.8% |
| INFINITY PHARMACEUTICALS INC | 29 | Q2 2023 | 4.3% |
| XOMA CORP DEL | 28 | Q3 2023 | 7.3% |
| ARQULE INC | 27 | Q4 2019 | 4.8% |
| CHEMOCENTRYX INC | 26 | Q3 2019 | 13.8% |
| CYTOMX THERAPEUTICS INC | 26 | Q3 2023 | 5.3% |
| CORVUS PHARMACEUTICALS INC | 26 | Q3 2023 | 2.3% |
| ARRAY BIOPHARMA INC | 25 | Q2 2019 | 14.5% |
View BVF INC/IL's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-13 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-01-29 |
| 3 | 2024-01-26 |
| 4 | 2024-01-09 |
| 4 | 2023-12-20 |
| 4 | 2023-11-17 |
| 13F-HR | 2023-11-14 |
| 3 | 2023-11-13 |
View BVF INC/IL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.